Advertisement

Topics

Eckert & Ziegler Radiopharma GmbH Company Profile

08:22 EDT 20th September 2018 | BioPortfolio


News Articles [225 Associated News Articles listed on BioPortfolio]

RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy

RaySearch and Eckert & Ziegler BEBIG, a leading European supplier of brachytherapy products, have signed a partnership agreement. Both the RayStation treatment planning system and the RayCare oncology...

Eckert & Ziegler BEBIG: First Half-Year Results 2018 Published

Seneffe - Belgium, July 31, 2018, Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) has announced today its half-year results 2018. The report including a...

Eckert & Ziegler BEBIG: Meeting Minutes Annual General Meeting

Seneffe, June 21, 2018. The Minutes and all relevant documents regarding the Annual General Assembly 2018 can be downloaded on the website: http://www.bebig.com/home/investors/sharehold...

Eckert & Ziegler BEBIG: Annual Report 2017 published

Regulated Information Seneffe - Belgium, April 30, 2018 - Eckert & Ziegler BEBIG (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB) announced today that its annual financial re...

Eckert & Ziegler is Manufacturing Partner for Bayer's Innovative Targeted Thorium Conjugates in Europe

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract 19.06.2018 / 14:29 The issuer is solely responsible for the content of this announcement. Berlin, 19 June...

Eckert & Ziegler Q1/2018: Sales increase of 9%; earnings remain below average

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Quarter Results 08.05.2018 / 07:45 The issuer is solely responsible for the content of this announcement. Berlin, ...

Eckert & Ziegler AG: Public Offer to Repurchase Shares

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Share Buyback Eckert & Ziegler AG: Public Offer to Repurchase Shares 16-Apr-2018 / 14:12 CET/CEST Disclosure of an inside inform...

Eckert & Ziegler: Defining the parameters of the public share buyback offer

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Share Buyback Eckert & Ziegler: Defining the parameters of the public share buyback offer 27-Apr-2018 / 18:30 CET/CEST Disclosur...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

The Walrus and the Carpenter: Complex Regulation of Tumor Immunity in Colorectal Cancer.

Immune infiltration has been correlated with survival of patients with colorectal cancer. In this issue, Ziegler et al. reveal complex and unexpected connections between loss of STAT3, mitophagy, and...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results.

Minimally invasive glaucoma surgery (MIGS) has been developed for all drainage pathways in glaucoma treatment. Besides implants overriding the resistance in the trabecular meshwork (iStent®, iStent I...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Clinical Trials [46 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [539 Associated Companies listed on BioPortfolio]

Eckert & Ziegler Radiopharma GmbH

Eckert & Ziegler AG

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with more than 700 employees, is one of the world’s largest providers of isotope technology for radiatio...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler BEBIG

Contributing to saving lives!

More Information about "Eckert & Ziegler Radiopharma GmbH" on BioPortfolio

We have published hundreds of Eckert & Ziegler Radiopharma GmbH news stories on BioPortfolio along with dozens of Eckert & Ziegler Radiopharma GmbH Clinical Trials and PubMed Articles about Eckert & Ziegler Radiopharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eckert & Ziegler Radiopharma GmbH Companies in our database. You can also find out about relevant Eckert & Ziegler Radiopharma GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record